{"id":24426,"date":"2024-05-21T14:36:43","date_gmt":"2024-05-21T12:36:43","guid":{"rendered":"https:\/\/ggba.swiss\/limula-secures-chf-6-2-million-to-advance-automated-cell-therapy-platform\/"},"modified":"2024-05-21T14:51:13","modified_gmt":"2024-05-21T12:51:13","slug":"limula-leve-chf-62-millions-pour-sa-plateforme-automatisee-de-therapie-cellulaire","status":"publish","type":"post","link":"https:\/\/ggba.swiss\/fr\/limula-leve-chf-62-millions-pour-sa-plateforme-automatisee-de-therapie-cellulaire\/","title":{"rendered":"Limula l\u00e8ve CHF 6,2 millions pour sa plateforme automatis\u00e9e de th\u00e9rapie cellulaire"},"content":{"rendered":"\n<p><a href=\"http:\/\/www.limula.ch\/\">Limula<\/a>, une soci\u00e9t\u00e9 lausannoise sp\u00e9cialis\u00e9e dans les sciences de la vie, a lev\u00e9 CHF 6,2 millions lors d&rsquo;un tour d&rsquo;amor\u00e7age sursouscrit afin de poursuivre le d\u00e9veloppement de sa plateforme automatis\u00e9e de fabrication de th\u00e9rapies cellulaires et g\u00e9niques (CGT). Le financement, men\u00e9 par <a href=\"http:\/\/www.lifex.vc\/\">LifeX Ventures<\/a> et soutenu par <a href=\"http:\/\/www.verve.vc\/\">Verve Ventures<\/a>, <a href=\"http:\/\/www.zuehlke.com\/en\/about-us\/ventures\">Z\u00fchlke Ventures<\/a>, <a href=\"https:\/\/www.sbs.ox.ac.uk\/research\/centres-and-initiatives\/entrepreneurship-centre\/oxford-seed-fund\">Oxford Seed Fund<\/a>, <a href=\"https:\/\/lichtsteinerfoundation.org\/\">Lichtsteiner Foundation<\/a>, <a href=\"https:\/\/devigier.ch\/\">W.A. de Vigier Foundation<\/a> et des investisseurs priv\u00e9s, marque une \u00e9tape importante dans la mission de Limula de rendre les th\u00e9rapies cellulaires et g\u00e9niques plus accessibles et abordables.<\/p>\n\n\n\n<p>Fond\u00e9e en 2020 par les docteurs Yann Pierson, Luc Henry et Thomas Eaton, Limula a pour objectif de r\u00e9volutionner le domaine des CGT en s&rsquo;attaquant aux co\u00fbts \u00e9lev\u00e9s et aux processus complexes associ\u00e9s aux m\u00e9thodes de fabrication actuelles. Leur plateforme innovante combine un bior\u00e9acteur et une centrifugeuse dans un seul r\u00e9cipient ferm\u00e9, automatisant la production de th\u00e9rapies cellulaires et \u00e9liminant le besoin d&rsquo;\u00e9tapes manuelles qui sont laborieuses et co\u00fbteuses.<\/p>\n\n\n\n<p>Dans le communiqu\u00e9 de presse de la soci\u00e9t\u00e9, le Dr Luc Henry, CEO de Limula, a d\u00e9clar\u00e9 : \u00ab Notre \u00e9quipe est motiv\u00e9e par l&rsquo;objectif ambitieux de d\u00e9velopper des outils bas\u00e9s sur une m\u00e9thode fondamentalement nouvelle de manipulation des cellules en dehors du corps. Notre technologie prend en charge des processus de fabrication qu&rsquo;il est impossible d&rsquo;automatiser avec les outils existants. Nous pensons que l&rsquo;automatisation est la seule voie vers l&rsquo;extensibilit\u00e9 et la tra\u00e7abilit\u00e9 num\u00e9rique. Ces deux aspects sont essentiels pour lib\u00e9rer tout le potentiel de la th\u00e9rapie cellulaire et g\u00e9nique et la rendre accessible au plus grand nombre.\u00a0\u00bb<\/p>\n\n\n\n<p>Les fonds lev\u00e9s seront utilis\u00e9s pour faire avancer le d\u00e9veloppement de la plateforme propri\u00e9taire de Limula, en veillant \u00e0 ce qu&rsquo;elle r\u00e9ponde aux exigences des bonnes pratiques de fabrication (BPF). Cela permettra aux fournisseurs de CGT de passer de l&rsquo;\u00e9valuation pr\u00e9clinique aux essais cliniques et finalement \u00e0 la fabrication \u00e0 l&rsquo;\u00e9chelle commerciale de produits cellulaires de qualit\u00e9 clinique. Limula travaille d\u00e9j\u00e0 avec des d\u00e9veloppeurs de th\u00e9rapies cellulaires s\u00e9lectionn\u00e9s pour mener des projets pilotes et pr\u00e9voit d&rsquo;int\u00e9grer d&rsquo;autres partenaires industriels et universitaires.<\/p>\n\n\n\n<h4 class=\"wp-block-heading\">Des millions de patients dans le monde entier<\/h4>\n\n\n\n<p>Limula a d\u00e9j\u00e0 re\u00e7u le <a href=\"https:\/\/ggba.swiss\/fr\/limula-et-le-csem-collaborent-pour-rendre-les-therapies-cellulaires-plus-abordables\/\">soutien du CSEM pour le prototypage et la pr\u00e9-industrialisation de sa technologie<\/a>, ainsi qu&rsquo;un <a href=\"https:\/\/ggba.swiss\/fr\/voltiris-limula-et-parithera-beneficient-du-start-up-fund-du-biopole\/\">financement du Biop\u00f4le Start-Up Fund<\/a>. Ces collaborations ont permis \u00e0 Limula de d\u00e9velopper une solution pr\u00e9industrielle qui est actuellement test\u00e9e pour la production de th\u00e9rapies cellulaires.<\/p>\n\n\n\n<p>Le Dr. Inaki Berenguer, Managing Partner chez LifeX Ventures, a exprim\u00e9 son enthousiasme pour le travail de Limula : \u00ab Nous sommes ravis d&rsquo;accompagner l&rsquo;\u00e9quipe de Limula dans sa r\u00e9invention de la fabrication des th\u00e9rapies cellulaires et g\u00e9niques. Il est \u00e9vident que les outils de production ont pris du retard par rapport aux avanc\u00e9es scientifiques et cliniques, notamment en termes de prix et d&rsquo;\u00e9volutivit\u00e9. L&rsquo;engagement de Limula \u00e0 s&rsquo;attaquer \u00e0 ces goulets d&rsquo;\u00e9tranglement est crucial pour am\u00e9liorer l&rsquo;accessibilit\u00e9 pour les patients.<\/p>\n\n\n\n<p>Compte tenu de l&rsquo;int\u00e9r\u00eat croissant pour les th\u00e9rapies innovantes, les solutions automatis\u00e9es et \u00e9volutives de Limula sont pr\u00eates \u00e0 avoir un impact significatif sur l&rsquo;industrie des soins de sant\u00e9, b\u00e9n\u00e9ficiant ainsi \u00e0 des millions de patients dans le monde.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>La soci\u00e9t\u00e9 vaudoise Limula a lev\u00e9 CHF 6,2 millions pour d\u00e9mocratiser l&rsquo;acc\u00e8s \u00e0 des th\u00e9rapies cellulaires et g\u00e9niques salvatrices.<\/p>\n","protected":false},"author":6,"featured_media":24423,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"inline_featured_image":false,"mc4wp_mailchimp_campaign":[],"footnotes":""},"categories":[843],"tags":[1169,1148,1188,1141,1171],"class_list":["post-24426","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-sciences-de-la-vie","tag-biotech-fr-2","tag-financing-fr-2","tag-healthcare-fr-2","tag-personalized-medicine-fr-2","tag-pharma-fr-2"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.2 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Limula l\u00e8ve CHF 6,2M pour sa plateforme de th\u00e9rapie cellulaire<\/title>\n<meta name=\"description\" content=\"La soci\u00e9t\u00e9 vaudoise Limula a lev\u00e9 CHF 6,2 millions pour d\u00e9mocratiser l&#039;acc\u00e8s \u00e0 des th\u00e9rapies cellulaires et g\u00e9niques salvatrices.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/ggba.swiss\/fr\/limula-leve-chf-62-millions-pour-sa-plateforme-automatisee-de-therapie-cellulaire\/\" \/>\n<meta property=\"og:locale\" content=\"fr_FR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Limula l\u00e8ve CHF 6,2M pour sa plateforme de th\u00e9rapie cellulaire\" \/>\n<meta property=\"og:description\" content=\"La soci\u00e9t\u00e9 vaudoise Limula a lev\u00e9 CHF 6,2 millions pour d\u00e9mocratiser l&#039;acc\u00e8s \u00e0 des th\u00e9rapies cellulaires et g\u00e9niques salvatrices.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/ggba.swiss\/fr\/limula-leve-chf-62-millions-pour-sa-plateforme-automatisee-de-therapie-cellulaire\/\" \/>\n<meta property=\"og:site_name\" content=\"Greater Geneva Bern area\" \/>\n<meta property=\"article:published_time\" content=\"2024-05-21T12:36:43+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2024-05-21T12:51:13+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/ggba.swiss\/app\/uploads\/2024\/05\/Limula-Founders-1180x811-1.jpeg\" \/>\n\t<meta property=\"og:image:width\" content=\"1180\" \/>\n\t<meta property=\"og:image:height\" content=\"811\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Pierre-Yves Oehrli\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"\u00c9crit par\" \/>\n\t<meta name=\"twitter:data1\" content=\"Pierre-Yves Oehrli\" \/>\n\t<meta name=\"twitter:label2\" content=\"Dur\u00e9e de lecture estim\u00e9e\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/ggba.swiss\/fr\/limula-leve-chf-62-millions-pour-sa-plateforme-automatisee-de-therapie-cellulaire\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/ggba.swiss\/fr\/limula-leve-chf-62-millions-pour-sa-plateforme-automatisee-de-therapie-cellulaire\/\"},\"author\":{\"name\":\"Pierre-Yves Oehrli\",\"@id\":\"https:\/\/staging.ggba.swiss\/en\/#\/schema\/person\/0b2e6d04131e3d01237dcb741fa33d41\"},\"headline\":\"Limula l\u00e8ve CHF 6,2 millions pour sa plateforme automatis\u00e9e de th\u00e9rapie cellulaire\",\"datePublished\":\"2024-05-21T12:36:43+00:00\",\"dateModified\":\"2024-05-21T12:51:13+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/ggba.swiss\/fr\/limula-leve-chf-62-millions-pour-sa-plateforme-automatisee-de-therapie-cellulaire\/\"},\"wordCount\":597,\"commentCount\":0,\"image\":{\"@id\":\"https:\/\/ggba.swiss\/fr\/limula-leve-chf-62-millions-pour-sa-plateforme-automatisee-de-therapie-cellulaire\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/ggba.swiss\/app\/uploads\/2024\/05\/Limula-Founders-1180x811-1.jpeg\",\"keywords\":[\"Biotech\",\"Financing\",\"Healthcare\",\"Personalized Medicine\",\"Pharma\"],\"articleSection\":[\"Sciences de la vie\"],\"inLanguage\":\"fr-FR\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/ggba.swiss\/fr\/limula-leve-chf-62-millions-pour-sa-plateforme-automatisee-de-therapie-cellulaire\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/ggba.swiss\/fr\/limula-leve-chf-62-millions-pour-sa-plateforme-automatisee-de-therapie-cellulaire\/\",\"url\":\"https:\/\/ggba.swiss\/fr\/limula-leve-chf-62-millions-pour-sa-plateforme-automatisee-de-therapie-cellulaire\/\",\"name\":\"Limula l\u00e8ve CHF 6,2M pour sa plateforme de th\u00e9rapie cellulaire\",\"isPartOf\":{\"@id\":\"https:\/\/staging.ggba.swiss\/en\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/ggba.swiss\/fr\/limula-leve-chf-62-millions-pour-sa-plateforme-automatisee-de-therapie-cellulaire\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/ggba.swiss\/fr\/limula-leve-chf-62-millions-pour-sa-plateforme-automatisee-de-therapie-cellulaire\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/ggba.swiss\/app\/uploads\/2024\/05\/Limula-Founders-1180x811-1.jpeg\",\"datePublished\":\"2024-05-21T12:36:43+00:00\",\"dateModified\":\"2024-05-21T12:51:13+00:00\",\"author\":{\"@id\":\"https:\/\/staging.ggba.swiss\/en\/#\/schema\/person\/0b2e6d04131e3d01237dcb741fa33d41\"},\"description\":\"La soci\u00e9t\u00e9 vaudoise Limula a lev\u00e9 CHF 6,2 millions pour d\u00e9mocratiser l'acc\u00e8s \u00e0 des th\u00e9rapies cellulaires et g\u00e9niques salvatrices.\",\"breadcrumb\":{\"@id\":\"https:\/\/ggba.swiss\/fr\/limula-leve-chf-62-millions-pour-sa-plateforme-automatisee-de-therapie-cellulaire\/#breadcrumb\"},\"inLanguage\":\"fr-FR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/ggba.swiss\/fr\/limula-leve-chf-62-millions-pour-sa-plateforme-automatisee-de-therapie-cellulaire\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\/\/ggba.swiss\/fr\/limula-leve-chf-62-millions-pour-sa-plateforme-automatisee-de-therapie-cellulaire\/#primaryimage\",\"url\":\"https:\/\/ggba.swiss\/app\/uploads\/2024\/05\/Limula-Founders-1180x811-1.jpeg\",\"contentUrl\":\"https:\/\/ggba.swiss\/app\/uploads\/2024\/05\/Limula-Founders-1180x811-1.jpeg\",\"width\":1180,\"height\":811,\"caption\":\"Les fondateurs de Limula (de gauche \u00e0 droite) : Luc Henry (CEO), Yann Pierson (CTO) et Thomas Eaton (COO). | \u00a9 CC-BY Jonathan Moy de Vitry RHRN.ch\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/ggba.swiss\/fr\/limula-leve-chf-62-millions-pour-sa-plateforme-automatisee-de-therapie-cellulaire\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/ggba.swiss\/fr\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Limula l\u00e8ve CHF 6,2 millions pour sa plateforme automatis\u00e9e de th\u00e9rapie cellulaire\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/staging.ggba.swiss\/en\/#website\",\"url\":\"https:\/\/staging.ggba.swiss\/en\/\",\"name\":\"Greater Geneva Bern area\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/staging.ggba.swiss\/en\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"fr-FR\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/staging.ggba.swiss\/en\/#\/schema\/person\/0b2e6d04131e3d01237dcb741fa33d41\",\"name\":\"Pierre-Yves Oehrli\",\"url\":\"https:\/\/ggba.swiss\/fr\/author\/pierre-yves-oehrli\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Limula l\u00e8ve CHF 6,2M pour sa plateforme de th\u00e9rapie cellulaire","description":"La soci\u00e9t\u00e9 vaudoise Limula a lev\u00e9 CHF 6,2 millions pour d\u00e9mocratiser l'acc\u00e8s \u00e0 des th\u00e9rapies cellulaires et g\u00e9niques salvatrices.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/ggba.swiss\/fr\/limula-leve-chf-62-millions-pour-sa-plateforme-automatisee-de-therapie-cellulaire\/","og_locale":"fr_FR","og_type":"article","og_title":"Limula l\u00e8ve CHF 6,2M pour sa plateforme de th\u00e9rapie cellulaire","og_description":"La soci\u00e9t\u00e9 vaudoise Limula a lev\u00e9 CHF 6,2 millions pour d\u00e9mocratiser l'acc\u00e8s \u00e0 des th\u00e9rapies cellulaires et g\u00e9niques salvatrices.","og_url":"https:\/\/ggba.swiss\/fr\/limula-leve-chf-62-millions-pour-sa-plateforme-automatisee-de-therapie-cellulaire\/","og_site_name":"Greater Geneva Bern area","article_published_time":"2024-05-21T12:36:43+00:00","article_modified_time":"2024-05-21T12:51:13+00:00","og_image":[{"width":1180,"height":811,"url":"https:\/\/ggba.swiss\/app\/uploads\/2024\/05\/Limula-Founders-1180x811-1.jpeg","type":"image\/jpeg"}],"author":"Pierre-Yves Oehrli","twitter_card":"summary_large_image","twitter_misc":{"\u00c9crit par":"Pierre-Yves Oehrli","Dur\u00e9e de lecture estim\u00e9e":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/ggba.swiss\/fr\/limula-leve-chf-62-millions-pour-sa-plateforme-automatisee-de-therapie-cellulaire\/#article","isPartOf":{"@id":"https:\/\/ggba.swiss\/fr\/limula-leve-chf-62-millions-pour-sa-plateforme-automatisee-de-therapie-cellulaire\/"},"author":{"name":"Pierre-Yves Oehrli","@id":"https:\/\/staging.ggba.swiss\/en\/#\/schema\/person\/0b2e6d04131e3d01237dcb741fa33d41"},"headline":"Limula l\u00e8ve CHF 6,2 millions pour sa plateforme automatis\u00e9e de th\u00e9rapie cellulaire","datePublished":"2024-05-21T12:36:43+00:00","dateModified":"2024-05-21T12:51:13+00:00","mainEntityOfPage":{"@id":"https:\/\/ggba.swiss\/fr\/limula-leve-chf-62-millions-pour-sa-plateforme-automatisee-de-therapie-cellulaire\/"},"wordCount":597,"commentCount":0,"image":{"@id":"https:\/\/ggba.swiss\/fr\/limula-leve-chf-62-millions-pour-sa-plateforme-automatisee-de-therapie-cellulaire\/#primaryimage"},"thumbnailUrl":"https:\/\/ggba.swiss\/app\/uploads\/2024\/05\/Limula-Founders-1180x811-1.jpeg","keywords":["Biotech","Financing","Healthcare","Personalized Medicine","Pharma"],"articleSection":["Sciences de la vie"],"inLanguage":"fr-FR","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/ggba.swiss\/fr\/limula-leve-chf-62-millions-pour-sa-plateforme-automatisee-de-therapie-cellulaire\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/ggba.swiss\/fr\/limula-leve-chf-62-millions-pour-sa-plateforme-automatisee-de-therapie-cellulaire\/","url":"https:\/\/ggba.swiss\/fr\/limula-leve-chf-62-millions-pour-sa-plateforme-automatisee-de-therapie-cellulaire\/","name":"Limula l\u00e8ve CHF 6,2M pour sa plateforme de th\u00e9rapie cellulaire","isPartOf":{"@id":"https:\/\/staging.ggba.swiss\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/ggba.swiss\/fr\/limula-leve-chf-62-millions-pour-sa-plateforme-automatisee-de-therapie-cellulaire\/#primaryimage"},"image":{"@id":"https:\/\/ggba.swiss\/fr\/limula-leve-chf-62-millions-pour-sa-plateforme-automatisee-de-therapie-cellulaire\/#primaryimage"},"thumbnailUrl":"https:\/\/ggba.swiss\/app\/uploads\/2024\/05\/Limula-Founders-1180x811-1.jpeg","datePublished":"2024-05-21T12:36:43+00:00","dateModified":"2024-05-21T12:51:13+00:00","author":{"@id":"https:\/\/staging.ggba.swiss\/en\/#\/schema\/person\/0b2e6d04131e3d01237dcb741fa33d41"},"description":"La soci\u00e9t\u00e9 vaudoise Limula a lev\u00e9 CHF 6,2 millions pour d\u00e9mocratiser l'acc\u00e8s \u00e0 des th\u00e9rapies cellulaires et g\u00e9niques salvatrices.","breadcrumb":{"@id":"https:\/\/ggba.swiss\/fr\/limula-leve-chf-62-millions-pour-sa-plateforme-automatisee-de-therapie-cellulaire\/#breadcrumb"},"inLanguage":"fr-FR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/ggba.swiss\/fr\/limula-leve-chf-62-millions-pour-sa-plateforme-automatisee-de-therapie-cellulaire\/"]}]},{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/ggba.swiss\/fr\/limula-leve-chf-62-millions-pour-sa-plateforme-automatisee-de-therapie-cellulaire\/#primaryimage","url":"https:\/\/ggba.swiss\/app\/uploads\/2024\/05\/Limula-Founders-1180x811-1.jpeg","contentUrl":"https:\/\/ggba.swiss\/app\/uploads\/2024\/05\/Limula-Founders-1180x811-1.jpeg","width":1180,"height":811,"caption":"Les fondateurs de Limula (de gauche \u00e0 droite) : Luc Henry (CEO), Yann Pierson (CTO) et Thomas Eaton (COO). | \u00a9 CC-BY Jonathan Moy de Vitry RHRN.ch"},{"@type":"BreadcrumbList","@id":"https:\/\/ggba.swiss\/fr\/limula-leve-chf-62-millions-pour-sa-plateforme-automatisee-de-therapie-cellulaire\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/ggba.swiss\/fr\/"},{"@type":"ListItem","position":2,"name":"Limula l\u00e8ve CHF 6,2 millions pour sa plateforme automatis\u00e9e de th\u00e9rapie cellulaire"}]},{"@type":"WebSite","@id":"https:\/\/staging.ggba.swiss\/en\/#website","url":"https:\/\/staging.ggba.swiss\/en\/","name":"Greater Geneva Bern area","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/staging.ggba.swiss\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"fr-FR"},{"@type":"Person","@id":"https:\/\/staging.ggba.swiss\/en\/#\/schema\/person\/0b2e6d04131e3d01237dcb741fa33d41","name":"Pierre-Yves Oehrli","url":"https:\/\/ggba.swiss\/fr\/author\/pierre-yves-oehrli\/"}]}},"_links":{"self":[{"href":"https:\/\/ggba.swiss\/fr\/wp-json\/wp\/v2\/posts\/24426","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/ggba.swiss\/fr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/ggba.swiss\/fr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/ggba.swiss\/fr\/wp-json\/wp\/v2\/users\/6"}],"replies":[{"embeddable":true,"href":"https:\/\/ggba.swiss\/fr\/wp-json\/wp\/v2\/comments?post=24426"}],"version-history":[{"count":2,"href":"https:\/\/ggba.swiss\/fr\/wp-json\/wp\/v2\/posts\/24426\/revisions"}],"predecessor-version":[{"id":24430,"href":"https:\/\/ggba.swiss\/fr\/wp-json\/wp\/v2\/posts\/24426\/revisions\/24430"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/ggba.swiss\/fr\/wp-json\/wp\/v2\/media\/24423"}],"wp:attachment":[{"href":"https:\/\/ggba.swiss\/fr\/wp-json\/wp\/v2\/media?parent=24426"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/ggba.swiss\/fr\/wp-json\/wp\/v2\/categories?post=24426"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/ggba.swiss\/fr\/wp-json\/wp\/v2\/tags?post=24426"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}